Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement, unanimously ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

Stifel Globus Medical’s (GMED) announced acquisition of Nevro (NVRO) an “unexpected move.” The firm says that while it wants to be ...

Globus Medical Inc. (NYSE:GMED), a medical device company with a market capitalization of $12 billion and an "GREAT" financial health rating according to InvestingPro, reaffirmed its commitment to ...

BTIG says Globus Medical’s (GMED) announced acquisition of Nevro (NVRO) “is surprising on the surface.” Investors did not expect Globus would ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

“2024 was an exceptional year of execution and achievement for Globus Medical. With the NuVasive merger ... merger and acquisition related costs, restructuring related costs, certain foreign ...

The upgrade comes after Globus Medical (TASE:PMCN)'s successful integration of NuVasive (NASDAQ ... to navigate the integration phase post-acquisition, which is a critical time for demonstrating ...

With the complementary strengths of Globus Medical engineering and NuVasive relations, education and training, GMED aims to outpace market growth, leading to accelerated EPS growth and an increase ...

BTIG analyst Ryan Zimmerman wrote in a research note on Thursday that the acquisition may surprise investors as Globus had just bought Nuvasive for $3.1 billion in 2023. “We don’t believe ...